Drug Price Reform Measures in the 2022 Inflation Reduction Act

The Inflation Reduction Act of 2022 is a budget reconciliation bill that addresses drug prices, corporate taxes, climate change, and energy security. It was passed by the U.S. Senate on August 7, 2022, passed by the U.S. House of Representatives on August 12, 2022, and signed into law on August 16, 2022, by President Biden.

Although the full impact of the bill is not yet understood, there are several provisions that would potentially impact drug prices. In this report, our team of clinical pharmacists deliver insight into the drug price reform measures in the 2022 Inflation Reduction Act and potential impacts to stakeholders in the market.